NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,147,657 | +0.9% | 11,267 | 0.0% | 0.07% | +3.0% |
Q2 2023 | $1,136,953 | +3.0% | 11,267 | -6.1% | 0.07% | -4.3% |
Q1 2023 | $1,103,632 | -6.2% | 11,996 | -7.5% | 0.07% | -17.6% |
Q4 2022 | $1,176,004 | +29.5% | 12,963 | +8.5% | 0.08% | +14.9% |
Q3 2022 | $908,000 | -99.9% | 11,952 | -0.7% | 0.07% | -3.9% |
Q2 2022 | $1,017,234,000 | +92040.8% | 12,034 | -4.4% | 0.08% | +4.1% |
Q1 2022 | $1,104,000 | -3.0% | 12,589 | -3.3% | 0.07% | 0.0% |
Q4 2021 | $1,138,000 | +4.4% | 13,021 | -4.8% | 0.07% | -5.1% |
Q3 2021 | $1,090,000 | -18.0% | 13,676 | -6.2% | 0.08% | -27.1% |
Q2 2021 | $1,330,000 | -8.5% | 14,586 | -14.2% | 0.11% | -11.6% |
Q1 2021 | $1,453,000 | -13.4% | 17,006 | -4.3% | 0.12% | -34.6% |
Q4 2020 | $1,678,000 | +243.1% | 17,779 | +228.5% | 0.18% | +55.5% |
Q3 2020 | $489,000 | +60.3% | 5,412 | +54.7% | 0.12% | +33.7% |
Q2 2020 | $305,000 | +48.1% | 3,498 | +39.4% | 0.09% | +14.1% |
Q1 2020 | $206,000 | -5.1% | 2,510 | +9.2% | 0.08% | +18.2% |
Q4 2019 | $217,000 | – | 2,298 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |